G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 94 filers reported holding G1 THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $695,000 | -34.7% | 46,900 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $1,065,000 | -0.8% | 46,900 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $1,074,000 | +27.1% | 46,900 | 0.0% | 0.00% | +33.3% |
| Q4 2020 | $845,000 | +463.3% | 46,900 | +263.6% | 0.00% | +200.0% |
| Q3 2020 | $150,000 | -74.4% | 12,900 | -31.4% | 0.00% | -66.7% |
| Q2 2019 | $585,000 | -15.3% | 18,800 | +63.5% | 0.00% | -25.0% |
| Q1 2019 | $691,000 | +283.9% | 11,500 | +22.3% | 0.00% | +300.0% |
| Q4 2018 | $180,000 | -74.0% | 9,400 | -18.3% | 0.00% | -75.0% |
| Q3 2018 | $691,000 | +37.1% | 11,500 | -2.5% | 0.00% | +33.3% |
| Q2 2018 | $504,000 | +19.1% | 11,800 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $423,000 | – | 11,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |